BRACANAT 150 – OLAPARIB TABLET 150 mg is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
Brand Name: BRACANAT 150
Composition: OLAPARIB 150 mg
Manufactured By: NATCO PHARMA LTD
Form: Tablet
Packing: Pack of 30 Tablets
PRESCRIPTION REQUIRED
There are no reviews yet.